In charts: The final report card of Buffett's era and Greg Abel’s challenges

Operating earnings fell nearly 30% y/y to $10.2B in Q4 2025, contributing to a near 5% one-day share decline and a peak ~14% sell-off since Buffett's May departure. Berkshire ends 2025 with $373.3B in cash and short-term Treasuries, a $4.5B impairment on Occidental/Kraft Heinz, underwriting profits down 54% to $1.56B and insurance investment income down ~25% to $3.1B, while CEO Greg Abel reiterates buyback/dividend restraint and a long-term, disciplined acquisition approach (including a $9.7B OxyChem deal).

Analysis

The market reaction has crystallised a structural change: a higher turnover shareholder base and a wider conglomerate discount. That shift amplifies price sensitivity to near-term earnings noise and increases the chance that minority holders force liquidity events or opportunistic buyers; expect impulse-driven volatility to persist for quarters, not days.

Insurance discipline under the new regime creates an underappreciated growth disconnect — slower P&C writing reduces future float growth, which mechanically lowers the substrate for investment compounding. That erosion is gradual but permanent absent aggressive redeployment of capital into high-return operating businesses; the easiest short-term lever (buybacks) is politically constrained, making valuation relief dependent on realized M&A IRR or a re-rating of core assets.

Second-order winners include active value acquirers and specialty insurers willing to trade scale for underwriting share; losers are legacy equity stakes in cyclical or commodity-linked names where impairment risk is now higher if management pursues bolt-on deals at premium multiples. Monitor dealer inventories, tax-lot selling patterns, and institutional flow data — a sustained increase in long-term holder selling is the highest-probability pathway to a multi-month underperformance versus the index.

Contrarian case: the market may be pricing permanent managerial conservatism as an inability to compound capital, which understates optionality in large, infrequent transformational deals. If a single high-IRR acquisition or a disciplined, opportunistic repurchase tranche is announced within 12–24 months, much of the discount can compress quickly; that’s the asymmetric event to hunt for.

Key Decisions for Investors

• Pair trade (6–12 months): Short BRK.B via a 4–6 month 1:1 put spread (buy 5–10% OTM puts, sell 15–20% OTM puts) sizing to 1–2% portfolio risk; go long AAPL shares or Jan 2028 LEAPS (TL 12–24 months) sized to offset tech exposure. Rationale: isolate conglomerate governance premium versus underlying high-quality tech cash flows. Target 2.5:1 reward-to-risk if BRK.B stays weak while AAPL rerates.
• Event hedge (3–9 months): Buy protection on KHC (buy 3–6 month out-of-the-money puts) sized small — high payoff if further impairments or restructuring announcements hit. Cost financed by selling farther OTM puts to limit premium spend. Expected asymmetric payoff >5:1 if goodwill/write-down momentum continues.
• Conservative long (12–24 months): Initiate a core long in MCO (Moody’s) — durable cash flows and upside from credit market volatility; add on spread-tightening or M&A announcements. Risk: economic downturn compresses credit fees; target IRR 10–15% with stop at 18% drawdown.
• Tactical short (days–weeks): If after-hours price gaps persist following earnings, opportunistically short OXY using a size-limited equity short or buy Feb–Mar short-dated put spreads to capture headline-driven downside. Exit on 30–50% realized gain or after a fundamental clarification from management.
• Monitoring trigger: set alerts for a material policy change (buyback bandwidth release, dividend initiation, or >$10bn transformational M&A). If triggered within 12 months, rotate 50–70% of BRK.B shorts into long recovery positions sized to capture a rapid 20–40% re-rate.